Allele Capital Partners
Founded in 2017, Allele Capital Partners is a merchant bank that provides venture capital and private equity financing to private and small-cap public life science companies. It offers strategic advisory services alongside proprietary and non-proprietary capital.
Top Regions
Top Stages
1 past transactions
Coya Therapeutics
Series A in 2021
Coya Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies that enhance the function of regulatory T cells (Tregs) in vivo. The company is advancing multiple first-in-class and best-in-class approaches, including allogeneic Treg-derived exosome therapeutics and novel biologics. Coya's proprietary medicinal products are designed to modulate Treg function, targeting a range of conditions such as neurodegenerative, autoimmune, and metabolic diseases. By harnessing the therapeutic potential of Tregs, Coya Therapeutics aims to address significant unmet medical needs in these critical areas of health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.